相关实验视频
Updated: Jun 21, 2025

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
1.6K
形甲状腺癌的新兴化疗治疗方法:对前性研究的最新分析
Bi-Cheng Wang1, Guo-He Lin2, Bo-Hua Kuang1
1Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Frontiers in endocrinology
|July 11, 2024
概括
化疗对厌塑性甲状腺癌 (ATC) 的生存益处有限. 新兴的基于化疗的治疗方法提供了一些抗瘤活性,但不能大大延长存活时间,需要新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 甲状腺癌研究研究
- 临床试验分析
背景情况:
- 无塑性甲状腺癌 (ATC) 通常缺乏驱动突变,使化疗成为建议的第一线选择.
- 目前,ATC的化疗效益有限,这凸显了改善治疗策略的必要性.
- 本分析重点关注自2010年以来ATC的新兴化疗治疗方法.
研究的目的:
- 综合分析基于化疗治疗形甲状腺癌的前性数据.
- 评估ATC患者新兴化疗方案的疗效和安全性.
- 确定未来ATC治疗开发的潜在领域.
主要方法:
- 在PubMed,Web of Science,Embase和Cochrane CENTRAL数据库 (2010-2024) 中进行系统搜索.
- 包括关于基于化疗的ATC治疗方法的前性临床研究.
- 汇总总体存活率 (OS),无进展存活率 (PFS),客观反应率 (ORR),疾病控制率 (DCR) 和与治疗相关的不良事件 (TRAE) 的数据.
主要成果:
- 我们分析了6项前性试验,包括232名ATC患者.
- 聚合的中位数OS为6.0个月,中位数PFS为3.2个月.
- 客观反应率 (ORR) 为21%,疾病控制率 (DCR) 为64%,并且68%的患者发生了等级≥3的TRAE.
结论:
- 新兴的基于化疗的治疗方法在厌塑性甲状腺癌中表现出抗瘤活性.
- 这些策略并没有显著延长ATC患者的存活时间.
- 进一步的研究对于开发更有效,更安全的ATC治疗方案至关重要.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Survival Analysis
340
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
340
Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K

